https://orcid.org/0000-0003-4799-7322
Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Muhammad Zubair, Sidra Khalil, Ijaz Rasul, Habibullah Nadeem, Fatima Noor, Sajjad Ahmad, Faris Alrumaihi, Khaled S. Allemailem, Ahmad Almatroudi, Faez Falah Alshehri & Zafer Saad Alshehri. (2023) Integrated molecular modeling and dynamics approaches revealed potential natural inhibitors of NF-κB transcription factor as breast cancer therapeutics. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-15.
Read now
Read now
Yasir Bashir, Fatima Noor, Sajjad Ahmad, Muhammad Hamza Tariq, Muhammad Qasim, Muhammad Tahir ul Qamar, Ahmad Almatroudi, Khaled S. Allemailem, Faris Alrumaihi & Faez Falah Alshehri. (2023) Integrated virtual screening and molecular dynamics simulation approaches revealed potential natural inhibitors for DNMT1 as therapeutic solution for triple negative breast cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-11.
Read now
Read now
Cafer Budak, Vasfiye Mençik & Veysel Gider. (2023) Determining similarities of COVID-19 – lung cancer drugs and affinity binding mode analysis by graph neural network-based GEFA method. Journal of Biomolecular Structure and Dynamics 41:2, pages 659-671.
Read now
Read now
N. Adhikari, S. Banerjee, S.K. Baidya, B. Ghosh & T. Jha. (2021) Robust classification-based molecular modelling of diverse chemical entities as potential SARS-CoV-2 3CLpro inhibitors: theoretical justification in light of experimental evidences. SAR and QSAR in Environmental Research 32:6, pages 473-493.
Read now
Read now
P.K. Singh, S. Pathania & R.K. Rawal. (2020) Exploring RdRp–remdesivir interactions to screen RdRp inhibitors for the management of novel coronavirus 2019-nCoV. SAR and QSAR in Environmental Research 31:11, pages 857-867.
Read now
Read now
Articles from other publishers (51)
Yingnan Liu, Wenhui Zhu, Menglin Han, Ying Bu, Jianrong Li & Xuepeng Li. (2023) Multi-spectroscopies and molecular simulation insights into the interaction mechanism of bovine serum albumin and syringaldehyde. Journal of Molecular Liquids 371, pages 121098.
Crossref
Crossref
Kamlesh Kumar, Prince Kumar, Dipankar Deb, Mihaela-Ligia Unguresan & Vlad Muresan. (2023) Artificial Intelligence and Machine Learning Based Intervention in Medical Infrastructure: A Review and Future Trends. Healthcare 11:2, pages 207.
Crossref
Crossref
Emmanuel Israel Edache, Adamu Uzairu, Paul Andrew Mamza & Gideon Adamu Shallangwa. (2022) QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate. Journal of Genetic Engineering and Biotechnology 20:1.
Crossref
Crossref
Madhur Babu Singh, Vijay Kumar Vishvakarma, Aditya Aryan Lal, Ramesh Chandra, Pallavi Jain & Prashant Singh. (2022) A comparative study of 5- fluorouracil, doxorubicin, methotrexate, paclitaxel for their inhibition ability for Mpro of nCoV: Molecular docking and molecular dynamics simulations. Journal of the Indian Chemical Society 99:12, pages 100790.
Crossref
Crossref
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Fatemeh Rameh, Masoomeh Nazarabi, Yousef Fatahi, Omid Akhavan, Mohammad Rabiee, Ebrahim Mostafavi, Eder C. Lima, Mohammad Reza Saeb & Navid Rabiee. (2022)
A review on computer‐aided chemogenomics and drug repositioning for rational
COVID
‐19 drug discovery
. Chemical Biology & Drug Design 100:5, pages 699-721.
Crossref
Crossref
Alessandra S. Rieder, Bruna F. Deniz, Carlos Alexandre Netto & Angela T.S. Wyse. (2022) A Review of In Silico Research, SARS-CoV-2, and Neurodegeneration: Focus on Papain-Like Protease. Neurotoxicity Research 40:5, pages 1553-1569.
Crossref
Crossref
Nader Namazi. (2022) The effectiveness of dexamethasone as a combination therapy for COVID-19. Acta Pharmaceutica 72:3, pages 345-358.
Crossref
Crossref
Paola Peluso & Bezhan Chankvetadze. (2022) Recognition in the Domain of Molecular Chirality: From Noncovalent Interactions to Separation of Enantiomers. Chemical Reviews 122:16, pages 13235-13400.
Crossref
Crossref
Miah Roney, Mohd Fadhlizil Fasihi Mohd Aluwi, Fuad Laman, Mohiuddin Ahmed Bhuiyan & AKM Moyeenul Huq. (2022)
Molecular Docking and
in silico
Evaluation of Phytochemicals of Bioactive Methanolic Extract of
Ipomoea mauritiana
Jacq. as Anti-Bacterial Agents
. Journal of Computational Biophysics and Chemistry 21:05, pages 499-513.
Crossref
Crossref
Rohit Patel, Jignesh Prajapati, Priyashi Rao, Rakesh M. Rawal, Meenu Saraf & Dweipayan Goswami. (2021) Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation. Molecular Diversity 26:4, pages 2189-2209.
Crossref
Crossref
Panagiotis Zagaliotis, Anthi Petrou, George Mystridis, Athina Geronikaki, Ioannis Vizirianakis & Thomas Walsh. (2022) Developing New Treatments for COVID-19 through Dual-Action Antiviral/Anti-Inflammatory Small Molecules and Physiologically Based Pharmacokinetic Modeling. International Journal of Molecular Sciences 23:14, pages 8006.
Crossref
Crossref
Kaifu Gao, Rui Wang, Jiahui Chen, Limei Cheng, Jaclyn Frishcosy, Yuta Huzumi, Yuchi Qiu, Tom Schluckbier, Xiaoqi Wei & Guo-Wei Wei. (2022) Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chemical Reviews 122:13, pages 11287-11368.
Crossref
Crossref
Vanja P. Ničkčović, Gordana R. Nikolić, Biserka M. Nedeljković, Nebojša Mitić, Snežana Filipović Danić, Jadranka Mitić, Zoran Marčetić, Dušan Sokolović & Aleksandar M. Veselinović. (2022) In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition. Chemical Papers 76:7, pages 4393-4404.
Crossref
Crossref
Mubarak A. Alamri, Muhammad Usman Mirza, Muhammad Muzammal Adeel, Usman Ali Ashfaq, Muhammad Tahir ul Qamar, Farah Shahid, Sajjad Ahmad, Eid A. Alatawi, Ghadah M. Albalawi, Khaled S. Allemailem & Ahmad Almatroudi. (2022) Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors. Pharmaceuticals 15:6, pages 659.
Crossref
Crossref
Cécilia Hognon, Marco Marazzi & Cristina García-Iriepa. (2022) Atomistic-Level Description of the Covalent Inhibition of SARS-CoV-2 Papain-like Protease. International Journal of Molecular Sciences 23:10, pages 5855.
Crossref
Crossref
Daratu Eviana Kusuma Putri, Harno Dwi Pranowo, Anugrah Ricky Wijaya, Novia Suryani, Maisari Utami, Artania Adnin Tri Suma, Woo Jin Chung, Saeedah Musaed Almutairi, Dina S. Hussein, Rabab Ahmed Rasheed & Venkatalakshmi Ranganathan. (2022) The predicted models of anti-colon cancer and anti-hepatoma activities of substituted 4-anilino coumarin derivatives using quantitative structure-activity relationship (QSAR). Journal of King Saud University - Science 34:3, pages 101837.
Crossref
Crossref
B Yogeswari, R Venkatesh, S Deivanayaki & D Prakash. (2022) Quantum Chemical Studies on SARS-CoV-2-a Review. Quantum Chemical Studies on SARS-CoV-2-a Review.
Nilanjan Adhikari, Suvankar Banerjee, Sandip Kumar Baidya, Balaram Ghosh & Tarun Jha. (2022) Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors: An analysis in light of structure-based multi-molecular modeling evidences. Journal of Molecular Structure 1251, pages 132041.
Crossref
Crossref
Hooman Aghamirza Moghim Aliabadi, Reza Eivazzadeh‐Keihan, Arezoo Beig Parikhani, Sara Fattahi Mehraban, Ali Maleki, Sepideh Fereshteh, Masoume Bazaz, Ashkan Zolriasatein, Bahareh Bozorgnia, Saman Rahmati, Fatemeh Saberi, Zeinab Yousefi Najafabadi, Shadi Damough, Sara Mohseni, Hamid Salehzadeh, Vahid Khakyzadeh, Hamid Madanchi, Gholam Ali Kardar, Payam Zarrintaj, Mohammad Reza Saeb & Masoud Mozafari. (2022) COVID‐19: A systematic review and update on prevention, diagnosis, and treatment. MedComm 3:1.
Crossref
Crossref
Haihai Jiang, Peiyao Yang & Jin Zhang. (2022) Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone. Frontiers in Chemistry 10.
Crossref
Crossref
Bolin Chen, Yourui Han, Xuequn Shang & Shenggui Zhang. (2022) A Novel COVID-19-Related Drug Discovery Approach Based on Non-Equidimensional Data Clustering. Frontiers in Pharmacology 13.
Crossref
Crossref
Yasunari Matsuzaka & Yoshihiro Uesawa. (2022) A Deep Learning-Based Quantitative Structure–Activity Relationship System Construct Prediction Model of Agonist and Antagonist with High Performance. International Journal of Molecular Sciences 23:4, pages 2141.
Crossref
Crossref
Paritosh Parmar, Priyashi Rao, Abhilasha Sharma, Arpit Shukla, Rakesh M. Rawal, Meenu Saraf, Baldev V. Patel & Dweipayan Goswami. (2021) Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow. Molecular Diversity 26:1, pages 389-407.
Crossref
Crossref
Priyashi Rao, Rohit Patel, Arpit Shukla, Paritosh Parmar, Rakesh M. Rawal, Meenu Saraf & Dweipayan Goswami. (2021) Identifying structural–functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation. Molecular Diversity 26:1, pages 309-329.
Crossref
Crossref
Sk. Abdul Amin, Kalyan Ghosh, Samayaditya Singh, Insaf Ahmed Qureshi, Tarun Jha & Shovanlal Gayen. (2021) Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery. Molecular Diversity 26:1, pages 215-228.
Crossref
Crossref
Jinxian Wang, Ying Zhang, Wenjuan Nie, Yi Luo & Lei Deng. (2022) Computational anti-COVID-19 drug design: progress and challenges. Briefings in Bioinformatics 23:1.
Crossref
Crossref
Farnoosh Kazemi, Mahdi Mojarrab, Gholamreza Bahrami, SeyedShahram Miraghaei, Saba Hadidi & MohammadBagher Majnooni. (2022) The alkaloids of Isatis indigotica as promising candidates against COVID-19: A molecular docking simulation for drug development. Journal of Reports in Pharmaceutical Sciences 11:2, pages 165.
Crossref
Crossref
Virupaksha Bastikar, Alpana Bastikar & Pramodkumar Gupta. 2022. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection. Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection
191
205
.
Amit Lochab, Rakhi Thareja, Sangeeta D. Gadre & Reena Saxena. (2021) Potential Protein and Enzyme Targets for In‐silico Development and Repurposing of Drug Against Coronaviruses. ChemistrySelect 6:46, pages 13363-13381.
Crossref
Crossref
Elvan Üstün, Serpil Demir Düşünceli, Feyzullah Coşkun & İsmail Özdemir. (2021) Molybdenum Carbonyl Complexes with Benzimidazole Derivatives Against SARS-CoV-2 by Molecular Docking and DFT/TDDFT Methods. Journal of Computational Biophysics and Chemistry 20:08, pages 815-827.
Crossref
Crossref
Ramesh Thimmasandra Narayan. (2021) Binding ability of arginine, citrulline, N-acetyl citrulline and thiocitrulline with SARS COV-2 main protease using molecular docking studies. Network Modeling Analysis in Health Informatics and Bioinformatics 10:1.
Crossref
Crossref
Indira Mikkili, Abraham Peele Karlapudi, T. C. Venkateswarulu, Vidya Prabhakar Kodali, Deepika Sri Singh Macamdas & Krupanidhi Sreerama. (2021) Potential of artificial intelligence to accelerate diagnosis and drug discovery for COVID-19. PeerJ 9, pages e12073.
Crossref
Crossref
Ponnusamy Packialakshmi, Perumal Gobinath, Kaliappillai Vijayakumar, Daoud Ali, Saud Alarifi, Balasubramani Ravindran, PitchaiSangan & Radhakrishnan Surendrakumar. (2021) Synthesis of Isatin Derivatives Using Silver Nanoparticles as Green Catalyst: Study of Molecular Docking Interactions in SARS-CoV-2 3c-Like Protease and Determination of Cytotoxic Activities of the Compounds. Journal of Nanomaterials 2021, pages 1-17.
Crossref
Crossref
Rohan Gupta, Devesh Srivastava, Mehar Sahu, Swati Tiwari, Rashmi K. Ambasta & Pravir Kumar. (2021) Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Molecular Diversity 25:3, pages 1315-1360.
Crossref
Crossref
Sk. Abdul Amin, Suvankar Banerjee, Samayaditya Singh, Insaf Ahmed Qureshi, Shovanlal Gayen & Tarun Jha. (2021) First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery. Molecular Diversity 25:3, pages 1827-1838.
Crossref
Crossref
Arun Bahadur Gurung, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah & Khalid Mashay Al-Anazi. (2021) An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19. BioMed Research International 2021, pages 1-18.
Crossref
Crossref
Vikas Kumar, Shraddha Parate, Sanghwa Yoon, Gihwan Lee & Keun Woo Lee. (2021) Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2. Frontiers in Microbiology 12.
Crossref
Crossref
Mohammad Ali Derakhshan, Amir Amani & Reza Faridi-Majidi. (2021) State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2. ACS Applied Materials & Interfaces 13:13, pages 14816-14843.
Crossref
Crossref
Ranjan K. Mohapatra, Lina Perekhoda, Mohammad Azam, Marharyta Suleiman, Ashish K. Sarangi, Anton Semenets, Lucia Pintilie & Saud I. Al-Resayes. (2021) Computational investigations of three main drugs and their comparison with synthesized compounds as potent inhibitors of SARS-CoV-2 main protease (Mpro): DFT, QSAR, molecular docking, and in silico toxicity analysis. Journal of King Saud University - Science 33:2, pages 101315.
Crossref
Crossref
Arabinda Ghosh, Monoswi Chakraborty, Anshuman Chandra & Mohamad Parvez Alam. (2021) Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (Mpro) of SARS-CoV-2. Journal of Molecular Modeling 27:3.
Crossref
Crossref
Abhishek Sengupta, Pooja Vijayaraghavan, Priyansh Srivastava, Lovely Gupta, Chaitanya Chandwani & Priyanka Narad. (2021) In-Silico Structure-Based Drug Discovery of Candidate Drugs against Novel Protein Receptor Complex Nsp10-Nsp16 of SARS-CoV-2 using Drug Repurposing Approach. Coronaviruses 2:2, pages 255-264.
Crossref
Crossref
Ziyad Tariq Muhseen, Alaa R. Hameed, Halah M. H. Al-Hasani, Sajjad Ahmad & Guanglin Li. (2021) Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2. Molecules 26:3, pages 674.
Crossref
Crossref
Kalyan Ghosh, Sk. Abdul Amin, Shovanlal Gayen & Tarun Jha. (2021) Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors. Journal of Molecular Structure 1224, pages 129026.
Crossref
Crossref
Sk. Abdul Amin, Suvankar Banerjee, Kalyan Ghosh, Shovanlal Gayen & Tarun Jha. (2021) Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors. Bioorganic & Medicinal Chemistry 29, pages 115860.
Crossref
Crossref
Ekampreet Singh, Rameez Jabeer Khan, Rajat Kumar Jha, Gizachew Muluneh Amera, Monika Jain, Rashmi Prabha Singh, Jayaraman Muthukumaran & Amit Kumar Singh. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
117
134
.
Pietro Delre, Fabiana Caporuscio, Michele Saviano & Giuseppe Felice Mangiatordi. (2020) Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease. Frontiers in Chemistry 8.
Crossref
Crossref
Julian Ivanov, Dmitrii Polshakov, Junko Kato-Weinstein, Qiongqiong Zhou, Yingzhu Li, Roger Granet, Linda Garner, Yi Deng, Cynthia Liu, Dana Albaiu, Jeffrey Wilson & Christopher Aultman. (2020) Quantitative Structure–Activity Relationship Machine Learning Models and their Applications for Identifying Viral 3CLpro- and RdRp-Targeting Compounds as Potential Therapeutics for COVID-19 and Related Viral Infections. ACS Omega 5:42, pages 27344-27358.
Crossref
Crossref
Anastasiia I. Petushkova & Andrey A. ZamyatninJr.Jr.. (2020) Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations. Pharmaceuticals 13:10, pages 277.
Crossref
Crossref
Sk Abdul Amin & Tarun Jha. (2020) Fight against novel coronavirus: A perspective of medicinal chemists. European Journal of Medicinal Chemistry 201, pages 112559.
Crossref
Crossref
Ahmed E. Allam, Hamdy K. Assaf, Heba Ali Hassan, Kuniyoshi Shimizu & Yaseen A. M. M. Elshaier. (2020)
An
in silico
perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19
. RSC Advances 10:50, pages 29983-29998.
Crossref
Crossref
Nilanjan Adhikari, Sk. Abdul Amin & Tarun Jha. 2021. In Silico Modeling of Drugs Against Coronaviruses. In Silico Modeling of Drugs Against Coronaviruses
329
431
.